Ivermectin's antiparasitic use is well-established, and its antiviral potential, especially against other single-stranded RNA viruses like Zika and Dengue, is a point worth considering. If it shows promise in lab settings for similar viruses, it's not unreasonable to think it might have some effect on SARS-CoV-2. The key is to look at the evidence with an open mind, not just dismiss it outright.

The real issue isn't whether it could work—it's about the quality of the research. While some studies are flawed or inconclusive, others show potential that deserves further exploration. We shouldn't ignore the possibility just because the results aren't perfect. Science is about testing ideas, even when they're controversial.

There's a lot we don't know about how viruses interact with our bodies, and Ivermectin is one of many drugs being studied. Being open to new possibilities, even if they're not fully proven, is part of what makes science progress. If there's a chance it could help, why not keep looking?